News

Davion Healthcare Plc has today appointed Mr Andreas Ttofi as Chief Financial Officer. Mr Toffi is an ACCA registered accountant and will oversee the company's financial operations globally. Also appointed today was Mr Jan Dulman as an Independent Director. Mr Dulman is a qualified CPA and will head up the company's Audit Committee as its Chairman.

Davion Healthcare Plc's registration statement filed on Form F-1 with the U.S. Securities and Exchange Commission was today made effective under Rule 8A. This now allows the company to register its shares for trading on the Nasdaq Stock Market.

Davion Healthcare Plc filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission for a proposed direct listing of its ordinary shares on the NASDAQ Global Market under the ticker symbol "DAVI."

Davion Healthcare Plc has opened a new Miami office for Davion Healthcare Corporation, which will oversee all U.S. operations, regulatory activity, and partner engagement in the region.

Davion Healthcare Plc has redomiciled its corporate headquarters from Limassol, Cyprus, to Cork, Ireland. Establishing its headquarters in Ireland provides closer alignment with Davion’s core EU and US markets, where the company will continue to develop and register its proprietary, non-invasive screening tests for use at home and in clinical settings.